Please enable JavaScript to continue using this application.

Compare $BMRN vs $IBRX | Chartloom

Compare

$BMRN vs $IBRX

BioMarin Pharmaceutical Inc · Immunitybio Inc

BMRN

BioMarin Pharmaceutical Inc

IBRX

Immunitybio Inc

Compare $BMRN vs $IBRX

Comparing BioMarin Pharmaceutical Inc and Immunitybio Inc

BMRNBioMarin Pharmaceutical Inc

IBRXImmunitybio Inc

BMRNBioMarin Pharmaceutical Inc

Market cap

$10.59B

P/E (TTM)

146.03x

Forward P/E (NTM)

12.82x

Forward P/S (NTM)

2.41x

Rev growth (TTM)

11.2%

YTD performance

-7.8%

52W performance

0.2%

FCF yield

6.8%

IBRXImmunitybio Inc

Market cap

$11.01B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

40.40x

Rev growth (TTM)

192.9%

YTD performance

420.3%

52W performance

315.4%

FCF yield

-2.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMRN

IBRX

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

IBRX

Immunitybio Inc

Market Cap

BMRN$10.59B

IBRX$11.01B

Enterprise Value

BMRN$13.90B

IBRX$12.12B

Price

BMRN$54.80

IBRX$10.51

P/E Ratio

BMRN146.03x

IBRXN/A

P/S Ratio

BMRN3.11x

IBRX66.39x

EV/Sales

BMRN4.08x

IBRX73.11x

EV/EBITDA

BMRN16.77x

IBRX0.00x

P/B Ratio

BMRN1.75x

IBRX73.35x

P/FCF Ratio

BMRN14.61x

IBRXN/A

EV/FCF

BMRN19.17x

IBRX-42.01x

PEG Ratio

BMRN4.10x

IBRXN/A

Forward P/E (NTM)

BMRN12.82x

IBRXN/A

Forward P/S (NTM)

BMRN2.41x

IBRX40.40x

Revenue (TTM)

BMRN$3.41B

IBRX$166M

Revenue Growth (YoY)

BMRN11.2%

IBRX192.9%

Forward Rev Growth

BMRN14.5%

IBRX111.5%

Gross Margin (TTM)

BMRN79.6%

IBRX99.3%

Operating Margin (TTM)

BMRN4.4%

IBRX0.0%

EBITDA Margin (TTM)

BMRN24.3%

IBRX-141.9%

Net Margin (TTM)

BMRN2.1%

IBRX-598.6%

FCF Margin (TTM)

BMRN21.3%

IBRX-174.0%

Net Income (TTM)

BMRN$73M

IBRX$-992M

FCF (TTM)

BMRN$725M

IBRX$-289M

EPS (TTM)

BMRN$0.38

IBRX-$0.95

ROE (TTM)

BMRN1.2%

IBRX-19329.0%

ROA (TTM)

BMRN82.0%

IBRX-17288.0%

ROIC (TTM)

BMRN93.0%

IBRX-19300.0%

Cash

BMRN$874M

IBRX$76M

Debt

BMRN$4.19B

IBRX$1.19B

Net Cash/Debt

BMRN$-3.31B

IBRX$-1.11B

Current Ratio (TTM)

BMRN2.39x

IBRX5.72x

Quick Ratio (TTM)

BMRN1.16x

IBRX5.36x

Debt/Equity (TTM)

BMRN0.66x

IBRX0.01x

Debt/Assets (TTM)

BMRN0.0%

IBRX0.0%

Interest Coverage (TTM)

BMRNN/A

IBRXN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

IBRX0.00x

Beta

BMRN0.23

IBRX0.17

52W Performance

BMRN0.2%

IBRX315.4%

YTD Performance

BMRN-7.8%

IBRX420.3%

% from 52W High

BMRN-22.8%

IBRX-15.4%

% from 52W Low

BMRN11.2%

IBRX439.0%

Asset Turnover (TTM)

BMRN0.38x

IBRX0.29x

FCF Yield (TTM)

BMRN6.8%

IBRX-2.6%

Earnings Yield (TTM)

BMRN0.7%

IBRX-9.0%

Dividend Yield (TTM)

BMRNN/A

IBRXN/A

Rule of 40

BMRN32.5

IBRX18.9

EV/GP/RG

BMRN0.18

IBRX1.12

Ticker research

View BMRN research View IBRX research

Metric	BMRN BioMarin Pharmaceutical Inc	IBRX Immunitybio Inc
Market & Valuation
Market Cap	$10.59B	$11.01B
Enterprise Value	$13.90B	$12.12B
Price	$54.80	$10.51
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	66.39x
EV/Sales	4.08x	73.11x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	73.35x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-42.01x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	40.40x
Revenue & Growth
Revenue (TTM)	$3.41B	$166M
Revenue Growth (YoY)	11.2%	192.9%
Forward Rev Growth	14.5%	111.5%
Profitability
Gross Margin (TTM)	79.6%	99.3%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-141.9%
Net Margin (TTM)	2.1%	-598.6%
FCF Margin (TTM)	21.3%	-174.0%
Net Income (TTM)	$73M	$-992M
FCF (TTM)	$725M	$-289M
EPS (TTM)	$0.38	-$0.95
ROE (TTM)	1.2%	-19329.0%
ROA (TTM)	82.0%	-17288.0%
ROIC (TTM)	93.0%	-19300.0%
Financial Health
Cash	$874M	$76M
Debt	$4.19B	$1.19B
Net Cash/Debt	$-3.31B	$-1.11B
Current Ratio (TTM)	2.39x	5.72x
Quick Ratio (TTM)	1.16x	5.36x
Debt/Equity (TTM)	0.66x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.17
52W Performance	0.2%	315.4%
YTD Performance	-7.8%	420.3%
% from 52W High	-22.8%	-15.4%
% from 52W Low	11.2%	439.0%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.29x
FCF Yield (TTM)	6.8%	-2.6%
Earnings Yield (TTM)	0.7%	-9.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	18.9
EV/GP/RG	0.18	1.12
Ticker research	View BMRN research	View IBRX research

Valuation

P/E Ratio

BMRN

146.03x

P/S Ratio

BMRN

3.11x

IBRX

66.39x

EV/FCF

IBRX

-42.01x

BMRN

19.17x

Growth & revenue

Revenue Growth TTM

IBRX

192.9%

BMRN

11.2%

Forward Revenue Growth

IBRX

111.5%

BMRN

14.5%

Profitability & performance

Gross Margin

IBRX

99.3%

BMRN

79.6%

ROE

BMRN

1.2%

IBRX

-19329.0%

FCF Yield %

BMRN

6.8%

IBRX

-2.6%

52-Week Performance

IBRX

315.4%

BMRN

0.2%

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

IBRX

Immunitybio Inc

Market Cap

BMRN$10.59B

IBRX$11.01B

Enterprise Value

BMRN$13.90B

IBRX$12.12B

Price

BMRN$54.80

IBRX$10.51

P/E Ratio

BMRN146.03x

IBRXN/A

P/S Ratio

BMRN3.11x

IBRX66.39x

EV/Sales

BMRN4.08x

IBRX73.11x

EV/EBITDA

BMRN16.77x

IBRX0.00x

P/B Ratio

BMRN1.75x

IBRX73.35x

P/FCF Ratio

BMRN14.61x

IBRXN/A

EV/FCF

BMRN19.17x

IBRX-42.01x

PEG Ratio

BMRN4.10x

IBRXN/A

Forward P/E (NTM)

BMRN12.82x

IBRXN/A

Forward P/S (NTM)

BMRN2.41x

IBRX40.40x

Revenue (TTM)

BMRN$3.41B

IBRX$166M

Revenue Growth (YoY)

BMRN11.2%

IBRX192.9%

Forward Rev Growth

BMRN14.5%

IBRX111.5%

Gross Margin (TTM)

BMRN79.6%

IBRX99.3%

Operating Margin (TTM)

BMRN4.4%

IBRX0.0%

EBITDA Margin (TTM)

BMRN24.3%

IBRX-141.9%

Net Margin (TTM)

BMRN2.1%

IBRX-598.6%

FCF Margin (TTM)

BMRN21.3%

IBRX-174.0%

Net Income (TTM)

BMRN$73M

IBRX$-992M

FCF (TTM)

BMRN$725M

IBRX$-289M

EPS (TTM)

BMRN$0.38

IBRX-$0.95

ROE (TTM)

BMRN1.2%

IBRX-19329.0%

ROA (TTM)

BMRN82.0%

IBRX-17288.0%

ROIC (TTM)

BMRN93.0%

IBRX-19300.0%

Cash

BMRN$874M

IBRX$76M

Debt

BMRN$4.19B

IBRX$1.19B

Net Cash/Debt

BMRN$-3.31B

IBRX$-1.11B

Current Ratio (TTM)

BMRN2.39x

IBRX5.72x

Quick Ratio (TTM)

BMRN1.16x

IBRX5.36x

Debt/Equity (TTM)

BMRN0.66x

IBRX0.01x

Debt/Assets (TTM)

BMRN0.0%

IBRX0.0%

Interest Coverage (TTM)

BMRNN/A

IBRXN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

IBRX0.00x

Beta

BMRN0.23

IBRX0.17

52W Performance

BMRN0.2%

IBRX315.4%

YTD Performance

BMRN-7.8%

IBRX420.3%

% from 52W High

BMRN-22.8%

IBRX-15.4%

% from 52W Low

BMRN11.2%

IBRX439.0%

Asset Turnover (TTM)

BMRN0.38x

IBRX0.29x

FCF Yield (TTM)

BMRN6.8%

IBRX-2.6%

Earnings Yield (TTM)

BMRN0.7%

IBRX-9.0%

Dividend Yield (TTM)

BMRNN/A

IBRXN/A

Rule of 40

BMRN32.5

IBRX18.9

EV/GP/RG

BMRN0.18

IBRX1.12

Ticker research

View BMRN research View IBRX research

Metric	BMRN BioMarin Pharmaceutical Inc	IBRX Immunitybio Inc
Market & Valuation
Market Cap	$10.59B	$11.01B
Enterprise Value	$13.90B	$12.12B
Price	$54.80	$10.51
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	66.39x
EV/Sales	4.08x	73.11x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	73.35x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-42.01x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	40.40x
Revenue & Growth
Revenue (TTM)	$3.41B	$166M
Revenue Growth (YoY)	11.2%	192.9%
Forward Rev Growth	14.5%	111.5%
Profitability
Gross Margin (TTM)	79.6%	99.3%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-141.9%
Net Margin (TTM)	2.1%	-598.6%
FCF Margin (TTM)	21.3%	-174.0%
Net Income (TTM)	$73M	$-992M
FCF (TTM)	$725M	$-289M
EPS (TTM)	$0.38	-$0.95
ROE (TTM)	1.2%	-19329.0%
ROA (TTM)	82.0%	-17288.0%
ROIC (TTM)	93.0%	-19300.0%
Financial Health
Cash	$874M	$76M
Debt	$4.19B	$1.19B
Net Cash/Debt	$-3.31B	$-1.11B
Current Ratio (TTM)	2.39x	5.72x
Quick Ratio (TTM)	1.16x	5.36x
Debt/Equity (TTM)	0.66x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.17
52W Performance	0.2%	315.4%
YTD Performance	-7.8%	420.3%
% from 52W High	-22.8%	-15.4%
% from 52W Low	11.2%	439.0%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.29x
FCF Yield (TTM)	6.8%	-2.6%
Earnings Yield (TTM)	0.7%	-9.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	18.9
EV/GP/RG	0.18	1.12
Ticker research	View BMRN research	View IBRX research